missing translation for 'onlineSavingsMsg'
Learn More

FBXO42 Mouse anti-Human, Clone: OTI1H4, liquid, TrueMAB™

Mouse Monoclonal Antibody

Brand:  Origene Technologies TA800283

Encompass_Preferred

Product Code. 17547992

  • € 540.87 / 100µL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

Members of the F-box protein family, such as FBXO42, are characterized by an approximately 40-amino acid F-box motif. SCF complexes, formed by SKP1, cullin, and F-box proteins, act as protein-ubiquitin ligases. F-box proteins interact with SKP1 through the F box, and they interact with ubiquitination targets through other protein interaction domains.
Specifications

Specifications

FBXO42
Monoclonal
1 mg/mL
PBS with 1% BSA, 50% glycerol and 0.02% sodium azide
Q6P3S6
FBXO42
Human recombit protein fragment corresponding to amino acids 356-717 of human FBXO42 produced in E.coli.
100 μL
Primary
Human
Antibody
IgG1
Flow Cytometry, Immunohistochemistry (Paraffin), Western Blot
OTI1H4
Unconjugated
FBXO42
Fbx42, JFK
Mouse
Affinity Chromatography
RUO
54455
-20° C, Avoid Freeze/Thaw Cycles
Liquid
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.